Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe ^sup 18^F-FBEM-Cys^sup 39^-exendin-4
Glucagon-like peptide-1 receptor (GLP-1R) is a specific target for insulinomas imaging since it is overexpressed in the tumor. Exendin-4 exhibits high affinity for the GLP-1R. In this study, a novel ^sup 18^F-labeled exendin-4 analog, ^sup 18^F-FBEM-Cys^sup 39^-exendin-4, was synthesized and its pot...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and clinical oncology 2014-09, Vol.140 (9), p.1479 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Glucagon-like peptide-1 receptor (GLP-1R) is a specific target for insulinomas imaging since it is overexpressed in the tumor. Exendin-4 exhibits high affinity for the GLP-1R. In this study, a novel ^sup 18^F-labeled exendin-4 analog, ^sup 18^F-FBEM-Cys^sup 39^-exendin-4, was synthesized and its potentials for GLP-1R imaging were also evaluated. ^sup 18^F-FBEM was synthesized by coupling ^sup 18^F-fluorobenzoic acid (^sup 18^F-FBA) with N-(2-aminoethyl) maleimide, and the reaction conditions were optimized. Cys^sup 39^-exendin-4 was then conjugated with ^sup 18^F-FBEM to obtain ^sup 18^F-FBEM-Cys^sup 39^-exendin-4. The GLP-1R targeting potential and pharmacokinetic profile of the tracer were analyzed in INS-1 insulinoma and MDA-MB-435 breast tumor model, respectively. Under the optimal conditions, the yield of radiolabeled ^sup 18^F-FBEM was 49.1 ± 2.0 % (based on ^sup 18^F-FBA, non-decay corrected). The yield of ^sup 18^F-FBEM-Cys^sup 39^-exendin-4 was 35.1 ± 2.6 % (based on the starting ^sup 18^F-FBEM, non-decay corrected). The radiochemical purity of ^sup 18^F-FBEM-Cys^sup 39^-exendin-4 is >95 %, and the specific activity was at least 35 GBq/[mu]mol. The GLP-1R-positive INS-1 insulinoma xenograft was clearly visible with good contrast to background, whereas GLP-1R-negative MDA-MB435 breast tumor was barely visible. Low levels of radioactivity were also detected at pancreas and lungs due to few GLP-1R expressions. GLP-1R binding specificity was demonstrated by reduced INS-1 tumor uptake of the tracer after coinjection with an excess of unlabeled Cys^sup 39^-exendin-4 at 1 h postinjection. The thiol-reactive reagent, ^sup 18^F-FBEM, was prepared with high yield and successfully conjugated to Cys^sup 39^-exendin-4. Favorable preclinical data showing specific and effective tumor targeting by ^sup 18^F-FBEM-Cys^sup 39^-exendin-4 suggest that the tracer may be a potential probe for insulinomas imaging.[PUBLICATION ABSTRACT] |
---|---|
ISSN: | 0171-5216 1432-1335 |
DOI: | 10.1007/s00432-014-1701-8 |